Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
PRParatek Pharmaceuticals, Inc. logo

Paratek Pharmaceuticals, Inc. (PRTK)

NASDAQ Global Market · Currency in USD
$2.23 ▲ +0.04 (+1.83%)
At close: Sep 20, 4:00 PM ET. Market closed.

Summary

Previous Close
$2.19
Open
$2.19
Day's Range
$2.19 – $2.24
52 Week Range
$1.29 – $3.65
Volume
4,476,125
Avg. Volume
631,339
Market Cap
$127.83M
Beta (5Y Monthly)
1.70
PE Ratio (TTM)
--
EPS (TTM)
-$1.17
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
Oct 31, 2014
1y Target Est
--

Profile: Paratek Pharmaceuticals, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
268
CEO
Evan Loh FACC, FAHA,

Paratek Pharmaceuticals, Inc., a biopharmaceutical firm headquartered in Boston, Massachusetts, and founded in 1996, is actively engaged in the commercialization of its products. The company's core mission involves the creation and market introduction of crucial medical treatments for severe illnesses or major public health crises, intended for civilian, governmental, and military applications. Their flagship therapeutic offerings include NUZYRA and SEYSARA.

Earnings

DateEst.Actual
Nov 2, 2023-$0.25-$0.38Miss
Aug 3, 2023$0.31$0.25Miss
May 9, 2023$0.38$0.35Miss
Mar 16, 2023$0.04$0.12Beat
Nov 3, 2022$0.27$0.38Beat
Aug 3, 2022$0.35$0.33Miss

Analyst view

Rating: Buy
Buy 71% · Hold 29% · Sell 0%

Get free alerts on PRTK and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.